Oragenics Inc (OGEN) stock
OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.20−0.15 (-42.59%)
Close on Nov 13, 2026Market cap $906.90KP/E –Yield –
Oragenics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Oragenics's ebitda for the twelve months ending Dec 31, 2023 was -$20.88M. For fiscal 2023 it was -$20.88M. The highest annual figure on record is -$5.79M in fiscal 2014.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -$20.88M | – |
| FY2022 | Dec 31, 2022 | -$14.38M | – |
| FY2021 | Dec 31, 2021 | -$15.73M | – |
| FY2020 | Dec 31, 2020 | -$26.59M | – |
| FY2019 | Dec 31, 2019 | -$15.81M | – |
| FY2018 | Dec 31, 2018 | -$9.96M | – |
| FY2017 | Dec 31, 2017 | -$6.65M | – |
| FY2016 | Dec 31, 2016 | -$8.47M | – |
| FY2015 | Dec 31, 2015 | -$11.71M | – |
| FY2014 | Dec 31, 2014 | -$5.79M | – |
| FY2013 | Dec 31, 2013 | -$16.13M | – |
| FY2012 | Dec 31, 2012 | -$12.36M | – |
| FY2011 | Dec 31, 2011 | -$7.27M | – |
| FY2010 | Dec 31, 2010 | -$7.86M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | -$12.80M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.09M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.10M | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.89M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.29M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.89M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.59M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.60M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.29M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.38M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.83M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.22M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.54M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.50M | – |
| Q2 FY2020 | Jun 30, 2020 | -$12.34M | – |
| Q1 FY2020 | Mar 31, 2020 | -$5.22M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.64M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.90M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.89M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.38M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.81M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.76M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.28M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.11M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.40M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.90M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.38M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.97M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.69M | – |
See a number that looks wrong?